01:49 PM EDT, 05/13/2024 (MT Newswires) -- Sanara MedTech ( SMTI ) reported Q1 net loss Monday of $0.21 per diluted share, widening from $0.14 a year earlier. One analyst polled by Capital IQ expected a loss of $0.07. Revenue for the quarter ended March 31 was $18.5 million, up from 15.5 million a year earlier. One analyst surveyed by...

01:50 PM EDT, 05/13/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 36.45, Change: +0.21, Percent...

Monday, Takeda Pharmaceutical Company Limited ( TAK ) and AC Immune SA ( ACIU ) announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta (Abeta), including ACI-24.060 for Alzheimer’s disease. ACI-24.060 is an anti-Abeta active immunotherapy candidate designed to induce an antibody response against the toxic forms of Abeta believed to drive plaque formation and Alzheimer’s...

MiNK Therapeutics, Inc. ( INKT ) shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million. What Happened: On Monday, MiNK Therapeutics ( INKT ) entered into a stock purchase agreement to sell securities in a private investment in public equity (PIPE) agreement. MiNK said it will sell 4.64 million shares at a price...